Evaluation of Decorin (DCN) Gene Expression as a Potential Biomarker in Patients with Severe Knee Osteoarthritis: A Pilot Study
Scientific Research Journal of Medical Sciences · 01.06.2026 · 6 (1) · 1-8
DOI: 10.47310/srjms.2026.v06i01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Research Journal of Medical Sciences, online erschienen am 01.06.2026. Verfasst von Sarah A. Younus und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Knee Osteoarthritis (KOA) is a degenerative pathology marked by progressive cartilage attrition and extracellular matrix (ECM) disruption, where Decorin (DCN) is a small, leucine-rich proteoglycan that provides a binding mechanism in chondrocyte biology, making it an important structural component for matrix integrity and the biomechanical function of cartilage.
Objective
To quantify DCN gene expression in KOA patients and evaluate its correlation with clinical severity. Methods: mRNA was extracted from whole blood samples of KOA patients (n=10) and healthy controls (n=10). Relative expression was determined via RT-qPCR using the 2-ΔΔCt method, normalized to GAPDH. Statistical analysis and visualization were performed using GraphPad Prism v.6.
Results
A highly significant upregulation of DCN expression was observed in the KOA cohort compared to controls (P<0.001), showing a fold-change of approximately 12. High expression levels demonstrated a strong positive correlation with advanced disease stages.
Conclusion
The marked elevation of DCN suggests a compensatory mechanism to mitigate ECM degradation. These findings highlight DCN as a sensitive molecular biomarker for KOA progression and therapeutic monitoring.
Zitieren
APA
Younus, S. A., M.A., Z., & Hamodatc (2026). Evaluation of Decorin (DCN) Gene Expression as a Potential Biomarker in Patients with Severe Knee Osteoarthritis: A Pilot Study. Scientific Research Journal of Medical Sciences, 6(1), 1-8. https://doi.org/10.47310/srjms.2026.v06i01.004
Vancouver
Younus SA, M.A. Z, Hamodatc. Evaluation of Decorin (DCN) Gene Expression as a Potential Biomarker in Patients with Severe Knee Osteoarthritis: A Pilot Study. Scientific Research Journal of Medical Sciences. 2026;6(1):1-8. doi:10.47310/srjms.2026.v06i01.004
BibTeX
@article{Younus2026,
author = {Younus, Sarah A. and M.A., Zahraa and Hamodatc},
title = {Evaluation of Decorin (DCN) Gene Expression as a Potential Biomarker in Patients with Severe Knee Osteoarthritis: A Pilot Study},
journal = {Scientific Research Journal of Medical Sciences},
year = {2026},
volume = {6},
number = {1},
pages = {1--8},
doi = {10.47310/srjms.2026.v06i01.004}
}
EUVIMED